Related references
Note: Only part of the references are listed.Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis
Xiaoyu Shu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease
Yinghui Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
Hyeon Seok Hwang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
Dae Kyu Kim et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Sarcopenia in chronic kidney disease: what have we learned so far?
Alice Sabatino et al.
JOURNAL OF NEPHROLOGY (2021)
Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy
Hideo Oishi et al.
JOURNAL OF CARDIOLOGY (2021)
Cytokines: From Clinical Significance to Quantification
Chao Liu et al.
ADVANCED SCIENCE (2021)
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
Hyeon Seok Hwang et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients
Yu Ho Lee et al.
BMC NEPHROLOGY (2020)
Molecular functions of FSTL1 in the osteoarthritis
Wencui Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach
Hiroshi Nishi et al.
NUTRIENTS (2020)
Follistatin-like 1 in development and human diseases
Andrea Mattiotti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Cardiovascular disease in dialysis patients
Mario Cozzolino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Quality of life as indicator of poor outcome in hemodialysis: relation with mortality in different age groups
I. N. van Loon et al.
BMC NEPHROLOGY (2017)
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture
Sonomi Maruyama et al.
EMBO MOLECULAR MEDICINE (2016)
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
Jeroen Slaats et al.
PLOS PATHOGENS (2016)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
Follistatin-like protein 1 and its role in inflammation and inflammatory diseases
Yury Chaly et al.
IMMUNOLOGIC RESEARCH (2014)
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells
Sven W. Goergens et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
The Relationship between Carotid Atherosclerosis, Inflammatory Cytokines, and Oxidative Stress in Middle-Aged and Elderly Hemodialysis Patients
Hongqi Ren et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2013)
Therapeutic Impact of Follistatin-Like 1 on Myocardial Ischemic Injury in Preclinical Models
Yasuhiro Ogura et al.
CIRCULATION (2012)
Follistatin-Like 1 in Chronic Systolic Heart Failure A Marker of Left Ventricular Remodeling
Ali El-Armouche et al.
CIRCULATION-HEART FAILURE (2011)
The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis
Marc Sylva et al.
PLOS ONE (2011)
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
Masayuki Shimano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis
Dawei Li et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Circulating Concentrations of Follistatin-Like 1 in Healthy Individuals and Patients with Acute Coronary Syndrome as Assessed by an Immunoluminometric Sandwich Assay
Christian Widera et al.
CLINICAL CHEMISTRY (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden
Anne M. Murray
ADVANCES IN CHRONIC KIDNEY DISEASE (2008)
MicroRNA-206: The skeletal muscle-specific myomiR
John J. McCarthy
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart
Yuichi Oshima et al.
CIRCULATION (2008)
Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism
Noriyuki Ouchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
AK Cheung et al.
KIDNEY INTERNATIONAL (2000)